Related Experiment Video
Updated: Aug 8, 2025
Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
[Extracellular Signal-regulated Kinase 1/2 Signaling Regulates Cell Invasion:a Review]
Xin-Ying Ge1, Lu-Lu Shao1, Xue-Lin Gao1
1Obstetrics Department of Lanzhou University Second Hospital,The Second Clinical Medical College of Lanzhou University,Lanzhou 730030,China.
Abstract:
Extracellular signal-regulated kinase 1/2 (ERK1/2) is a serine/threoninekinase involved in the signal transduction cascade of Ras-Raf-mitogen-activated protein kinase (MEK)-ERK.It participates in the cell growth,proliferation and even invasion by regulating gene transcription and expression.The occurrence of a variety of diseases such as lung cancer,liver cancer,ovarian cancer,cervical cancer,endometriosis,and preeclampsia,as well the metastasis and disease progression,is closely associated with the regulation of cell invasion by ERK1/2 signaling pathway.Therefore,exploring the regulation of ERK1/2 signaling on cell invasion and its role in pathogenesis of diseases may help to develop more effective treatment schemes.This article introduces recent progress in the regulation of ERK1/2 signaling on cell invasion and the role of such regulation in diseases,with a view to give new insights into the clinical treatment of ERK 1/2-related diseases.
Insights
The ERK1/2 pathway regulates cell invasion, impacting diseases like cancer and preeclampsia. Understanding this signaling is key to developing new treatments for related conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Extracellular signal-regulated kinase 1/2 (ERK1/2) is a key kinase in the Ras-Raf-MEK-ERK signaling cascade.
- ERK1/2 regulates critical cellular processes including growth, proliferation, and invasion by controlling gene expression.
Approach:
- This review synthesizes recent research on ERK1/2's role in cell invasion.
- It examines the pathway's involvement in the pathogenesis of various diseases.
Key Points:
- ERK1/2 signaling is implicated in the progression and metastasis of cancers like lung, liver, ovarian, and cervical cancer.
- Dysregulation of ERK1/2 contributes to conditions such as endometriosis and preeclampsia.
- The pathway's influence on cell invasion is a critical factor in disease development.
Conclusions:
- Targeting the ERK1/2 pathway offers potential for novel therapeutic strategies.
- Further insights into ERK1/2-mediated cell invasion can guide clinical treatments for related diseases.
